Pt Kalbe Farma Tbk · IDX:KLBF
Pt Kalbe Farma Tbk — H1 2025 Earnings Presentation
48 slides from Pt Kalbe Farma Tbk's earnings presentation, August 2025
Slide 1: Company Presentation
Aug 2025 PT Kalbe Farma Tbk (KLBF IJ/KLBF.JK) Company Presentation YTD Jun 2025 11
Slide 2: Forward-Looking Statement
Forward-Looking Statement This presentation has been prepared for informational purposes only by PT Kalbe Farma Tbk. (“Kalbe” or the “Company”). This presentation has been prepared solely for use in connection with the release of 30 June 2025 unaudited results of the Company. The information contain
Slide 3: Table of Contents
Table of Contents • Key Updates 04 • Business Strategies 09 • Financial Overview 24 • Appendix 1 31 • Appendix 2 38 3
Slide 4: Key Updates
1) oO ~ i) xe) . = > oO x
Slide 5: More than Half a Century of Providing Wide-Range Healthcare Solutions
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II More than Half a Century of Providing Wide-Range Healthcare Solutions Corporate Overview 7% 93% Export Domestic 33.3% 28.9% Distribution & Prescription Logisti
Slide 6: Solid Foundation for Future Growth
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Solid Foundation for Future Growth Key Takeaways 4.6% 9.4% net sales net profit Key Updates Key Risks Positive organic top-line growth driven by volume Pressur
Slide 7: Driving Growth and Improving Healthcare Resilience through Innovation
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Driving Growth and Improving Healthcare Resilience through Innovation 2025 Key Strategies Investing for long term growth through innovation and collaboration •
Slide 8: Rejuvenating Our Strong Brands to Win the Market
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Rejuvenating Our Strong Brands to Win the Market A group of kids holding a trophy AI-generated content may be incorrect. A person carrying a person A yellow ca
Slide 9: Prescription Pharmaceuticals
Prescription Pharmaceuticals 9
Slide 10: Driving Top Line Growth with Portfolio Strategy
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Prescription Pharmaceuticals Driving Top Line Growth with Portfolio Strategy Building Specialty Portfolio Growing specialty category by commercialization and e
Slide 11: Strategic Collaborations to Accelerate Growth
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Strategic Collaborations to Accelerate Growth Prescription Pharmaceuticals Global Starway Synergy Kalventis Alliance Pharma Livzon Pharma Indonesia Dec 2022 De
Slide 12: Innovative Specialty Products
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Innovative Specialty Products Prescription Pharmaceuticals Manufacturing Facilities Specialty Portfolio Biologics • In line with government local Serplulimab E
Slide 13: Sustaining Growth Through Our Complete Portfolio
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Sustaining Growth Through Our Complete Portfolio Prescription Pharmaceuticals 9.4% 51.1% net sales growth gross profit margin from Rp4,516 bn to 4,941 bn from
Slide 14: Rejuvenating Our Strong Brands to Win the Market
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Consumer Health Rejuvenating Our Strong Brands to Win the Market Expanding Customer Base Leveraging solid customer base in OTC and health supplement with brand
Slide 15: Expanding into Preventive Category
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Expanding into Preventive Category Consumer Health ~30-70% market share in Driving product innovation and new product launches in potential relevant categories
Slide 16: Driving Growth Through Brand Rejuvenation
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Driving Growth Through Brand Rejuvenation Consumer Health 5.3% 64.7% net sales growth gross profit margin from Rp2,322 bn to 2,445 bn from 61.8% due to product
Slide 17: Navigating the Market and Driving Future Growth
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Nutritionals Navigating the Market and Driving Future Growth Solid Product Portfolio Complete product offering for all life stages with strong functionality an
Slide 18: Complete Portfolio for Future Expansion
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Complete Portfolio for Future Expansion Nutritionals Expecting Mothers Senior & Clinical Lactating Mothers Complete product Adults offering for all Kids life s
Slide 19: Navigating Market Challenges
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Navigating Market Challenges Nutritionals -3.3% 55.3% net sales growth gross profit margin from Rp4,139 bn to 4,004 bn from 51.4% due to product mix Specialty
Slide 20: Strong Distribution Network in Healthcare, Supported by Digital Expansion
Key updates Key updates Business StrategyStrategy Business Appendix II Appendix II Distribution and Logistics Strong Distribution Network in Healthcare, Supported by Digital Expansion Strong Distribution Infrastructure Expansive multi-channels network with coverage in 72 branches Access to healthcar
Slide 21: Extensive Network in Pharmaceuticals Distribution
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Extensive Network in Pharmaceuticals Distribution Distribution & Logistics 72 Branches Distribution 3 Centers +200K Outlets Prescription Pharmaceuticals Consum
Slide 22: Moving Towards Local Manufacturing & Assembly
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Moving Towards Local Manufacturing & Assembly Medical Devices Production & Assembly Facilities Medical Equipment Mobile X-ray CT Scan Dialyzer commercialized i
Slide 23: The Largest Distribution Network in Healthcare
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II The Largest Distribution Network in Healthcare, Supported by Digital Expansion Distribution & Logistics 6.3% 12.4% net sales growth gross profit margin from Rp
Slide 24: Financial Overview
: Financial Overview ma
Slide 25: Continued Top-line Growth
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Continued Top-line Growth Consolidated Operational Performance Net Sales In IDR bn (unaudited) 4.6% 17,079 16,328 9.4% 5.3% 3.3% 6.3% 4,941 5,351 5,690 4,516 4
Slide 26: Sustaining Margin
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Sustaining Margin Consolidated Operational Performance Gross Profit Operating Expenses to Net Sales Net Income 25.5% 26.8% 39.6% 41.1% 11.1% 11.6% 1.3% 1.4% 4.
Slide 27: Securing Product Availability by Managing Inventory
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Securing Product Availability by Managing Inventory Working Capital Management Managing Net Operating Cycle 162 153 • Normalizing inventory level 144 138 • Imp
Slide 28: Healthy Cash Balance to Support Operation and Business Expansion
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Healthy Cash Balance to Support Operation and Business Expansion Capital Allocation Total Debt & Gearing Ratio Cash & Net Cash 5.1% Cash Total Debt Net Cash Ge
Slide 29: Securing Top and Bottom-Line Growth
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Securing Top and Bottom-Line Growth Outlook 2025 Driving top line growth Sustaining profitability Consistently optimizing across businesses shareholders' retur
Slide 30: Thank You
Thank You For further information : PT Kalbe Farma Tbk | Jalan Let. Jend. Suprapto Kav. 4 | Jakarta 10510, Indonesia Tel. : 62-21-42873888 | Fax. : 62-21-42873678 Email : syeren.amanda@kalbecorp.com investor.relations@kalbecorp.com 30 30
Slide 31: Appendix 1
Appendix 1 31
Slide 32: Sustained Top-line Growth and Resilient Margins Over a Decade
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Sustained Top-line Growth and Resilient Margins Over a Decade Key Takeaways • Sustained consolidated top-line growth at 16,367 16,603 CAGR 6.2% over a decade.
Slide 33: Focus on Increasing National Healthcare Resiliency Amidst Macroeconomy Dynamics
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Focus on Increasing National Healthcare Resiliency Amidst Macroeconomy Dynamics Market Overview GDP Consumer Confidence Index 127.7 125.0 5.31% 5.05% 5.03% 121
Slide 34: Growing National Health Insurance Coverage and Increasing Health Budget
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Growing National Health Insurance Coverage and Increasing Health Budget Healthcare Industry Overview Population In million National Health Insurance (JKN) Cove
Slide 35: Ensuring Compliance and Support to Government Strategic Program
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Ensuring Compliance and Support to Government Strategic Program Recent Pharma Regulations Government Regulation Number 42 of 2024 • Requirement of Halal certif
Slide 36: Access to Healthcare for a Better Life
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Access to Healthcare for a Better Life Gradual Improvement of ESG Practices Based on International Standards Energy Efficiency and C02 Emission Reduction E Gra
Slide 37: Sustainability Activities
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Sustainability Activities Improving Access to Healthcare and Implementing Responsible Business Practices Proper Hijau Received the 2024 Proper Hijau for PT Kal
Slide 38: Appendix 2
Appendix 2 38
Slide 39: Financial Statement
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Financial Statement CONSOLIDATED STATEMENT Dec 24 Jun 25 Change OF FINANCIAL POSITION (Audited) (Unaudited) YTD ASSETS CURRENT ASSETS Cash and Cash Equivalents
Slide 40: Financial Statement
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Financial Statement CONSOLIDATED STATEMENT Dec 24 Jun 25 Change OF FINANCIAL POSITION (Audited) (Unaudited) YTD ASSETS LIABILITIES CURRENT LIABILITIES CURRENT
Slide 41: Financial Statement
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Financial Statement CONSOLIDATED STATEMENT Dec 24 Jun 25 Change OF FINANCIAL POSITION (Audited) (Unaudited) YTD ASSETS EQUITY CURRENT Capital ASSETS Stock - Is
Slide 42: Financial Statement
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Financial Statement CONSOLIDATED STATEMENT OF PROFIT OR LOSS Jun 24 Jun 25 Change YoY AND OTHER COMPREHENSIVE INCOME (Unaudited) (Unaudited) NET SALES NET SALE
Slide 43: Financial Statement
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Financial Statement CONSOLIDATED STATEMENT OF PROFIT OR LOSS Jun 24 Jun 25 Change YoY AND OTHER COMPREHENSIVE INCOME (Unaudited) (Unaudited) NET SALES Non-oper
Slide 44: Financial Statement
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Financial Statement CONSOLIDATED STATEMENT OF PROFIT OR LOSS Jun 24 Jun 25 Change YoY AND OTHER COMPREHENSIVE INCOME (Unaudited) (Unaudited) NET SALES 16,328,2
Slide 45: Financial Statement
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Financial Statement Jun 24 Jun 25 Change CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) (Unaudited) YoY CASH FLOWS FROM CASH FLOWS FROM OPERATING OPERATING A
Slide 46: Financial Statement
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Financial Statement Jun 24 Jun 25 Change CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) (Unaudited) YoY CASH FLOWS FROM OPERATING ACTIVITIES INVESTING ACTIVI
Slide 47: Financial Statement
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Financial Statement Jun 24 Jun 25 Change CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) (Unaudited) YoY CASH FLOWS FROM OPERATING ACTIVITIES FINANCING ACTIVI
Slide 48: Financial Statement
Key updates Business StrategyStrategy Financial Updates Appendix I Appendix II Key updates Business Financial Updates Appendix I Appendix II Financial Statement Jun 24 Jun 25 Change CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) (Unaudited) YoY CASH FLOWS FROM NET INCREASE OPERATING (DECREASE) ACT